Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study.
Abstract Background Type 2 diabetes (T2DM) and COPD are chronic conditions, for which patients need lifelong healthcare. The aim of the study is to examine in which healthcare setting patients with T2DM and COPD receive care, and if they are allocated to the correct setting.Method T2DM and COPD patients from five primary care centres were included. Data concerning treatment setting, patient- and clinical characteristics were extracted from electronic medical records. The profile of patients treated in primary care was compared with that of those treated in secondary care. For patients treated in secondary care we evaluated whether treatment allocation was according to guidelines and if back-referral to primary care could take place.Results Of the T2DM and COPD patients 7.6% and 29.6% were treated in secondary care of which 72.7% and 31.4% according to the guideline. T2DM patients treated in primary care were older (63 versus 57 years, p = 0.001), had a shorter diabetes duration (8 versus 11 years, p < 0.001) and lower HbA1c (53.0 versus 63.5 mmmol/l, p < 0.001) than those treated in secondary care. Those with COPD treated in primary care used less inhalation medication (75.2 versus 90.1%, p < 0.001) and had better spirometry results (67.39 versus 57.53 FEV1%pred, p < 0.001).Conclusion The majority of the patients with T2DM and COPD were treated in primary care correctly. Patients treated in primary care on average had a better health condition compared to those in secondary care. The majority of the T2DM patients and the minority of COPD patients were treated correctly in secondary care.